Stocks
Vanda Pharmaceuticals (VNDA) Debt/EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| Debt/EBITDA | -9.34 | -50.3 | 34.6 | 11.1 | 1.80 | 1.18 | ||
| Changes by years, y/y, % | -21% | +438% | -169% | -68% | -84% | |||
Vanda Pharmaceuticals. Debt/EBITDA
Vanda Pharmaceuticals. Debt/EBITDA, changes, %
Vanda Pharmaceuticals (VNDA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 3.86 | 2.79 | 1.97 | 1.33 | 1.32 | 1.18 | ||
| Changes by years, y/y, % | -73% | -77% | -82% | -77% | -77% | |||
| Changes by quarters, q/q, % | -34% | -28% | -29% | -32% | -1% | |||
